Grifols reported a profit of 390 million euros in the first nine months of 2026, a 28.9% increase compared to the previous year, thanks to the boost from the biopharma business and the implementation of a restructuring plan, despite a decline in financial results. #Grifols #biofarma #dividendo (translated)
www.lavanguardia.com
Grifols gana un 28,9% más impulsada por el negocio de biofarma y tras un plan de ajustes
